Ponni Subbiah leads our work in drug development. Photo: PATH/Scott Brown.
Program Leader, Drug Development
Ponni Subbiah, MD, MPH, directs PATH’s drug development program, which seeks to discover, develop, and deliver safe, effective, and affordable treatments for neglected diseases in the developing world. Prior to joining PATH, Dr. Subbiah spent 15 years with Pfizer Inc., where her most recent position was vice president of global access within the Emerging Markets Business Unit. In that position, she led the company’s global access strategy and worked with a variety of public- and private-sector partners, including Grameen and the Clinton Foundation.
Other positions Dr. Subbiah held at Pfizer include vice president of global medical affairs for the Urology/Respiratory Group and vice president of US medical affairs for the Arthritis, Pain, Metabolic, and Neuroscience Groups. In these positions, she provided strategic direction for clinical research and medical management for a range of drugs.
While at Pfizer, Dr. Subbiah spent time as a Pfizer Global Health Fellow, teaching and providing patient care at Mulago Hospital in Kampala, Uganda. She also has volunteered in a range of settings, including working with HIV-positive individuals and AIDS orphans in Uganda. Before joining Pfizer, she worked as a neurologist in several facilities in Fresno, California.
Dr. Subbiah received the Asian Women in Business Corporate Leadership award, Pfizer NY Site Change Agent award, and Pfizer W.E. Upjohn Award for Community Service. She received her medical degree from Madras Medical College in India and her MPH from Johns Hopkins University in Baltimore, Maryland.